Spirepoint Private Client’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$925K Hold
10,856
0.09% 127
2025
Q4
$858K Buy
10,856
+85
+0.8% +$6.66K 0.08% 126
2025
Q3
$861K Sell
10,771
-350
-3% -$29.9K 0.09% 127
2025
Q2
$1.01M Hold
11,121
0.11% 108
2025
Q1
$1.04M Sell
11,121
-245
-2% -$21.9K 0.14% 89
2024
Q4
$1.03M Buy
11,366
+1,644
+17% +$157K 0.13% 96
2024
Q3
$1.01M Sell
9,722
-1
-0% -$102 0.13% 99
2024
Q2
$944K Buy
+9,723
New +$897K 0.13% 99

Other funds holding CL

Spirepoint Private Client's CL Position: Q1 2026 in Review

Spirepoint Private Client held its Colgate-Palmolive (CL) position steady in Q1 2026 at 10,856 shares worth $925K. The position accounts for 0.09% of the portfolio, ranked #127.

Spirepoint Private Client first reported a position in CL in Q2 2024 and has held it in 8 quarters since. The position peaked at $1.04M in Q1 2025. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Spirepoint Private Client held 10,856 shares of Colgate-Palmolive worth $925K as of Q1 2026.
  • Spirepoint Private Client left its Colgate-Palmolive share count unchanged in Q1 2026.
  • Colgate-Palmolive made up 0.09% of Spirepoint Private Client's portfolio in Q1 2026, its #127 holding.
  • Spirepoint Private Client first reported a position in Colgate-Palmolive in Q2 2024 and has held it in 8 quarters since.
  • Spirepoint Private Client's Colgate-Palmolive position peaked at $1.04M in Q1 2025.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Spirepoint Private Client's 13F filing for Q1 2026, filed 22 Apr 2026.